Bi-exponential diffusion-weighted imaging for differentiating high-grade gliomas from solitary brain metastases: a VOI-based histogram analysis
- PMID: 39738411
- PMCID: PMC11685987
- DOI: 10.1038/s41598-024-83452-x
Bi-exponential diffusion-weighted imaging for differentiating high-grade gliomas from solitary brain metastases: a VOI-based histogram analysis
Abstract
This study investigated the use of bi-exponential diffusion-weighted imaging (DWI) combined with structural features to differentiate high-grade glioma (HGG) from solitary brain metastasis (SBM). A total of 57 patients (31 HGG, 26 SBM) who underwent pre-surgical multi-b DWI and structural MRI (T1W, T2W, T1W + C) were included. Volumes of interest (VOI) in the peritumoral edema area (PTEA) and enhanced tumor area (ETA) were selected for analysis. Histogram features of slow diffusion coefficient (Dslow), fast diffusion coefficient (Dfast), and perfusion fraction (frac) were extracted. Results showed that HGG patients had higher skewness of Dfast (P = 0.022) and frac (P = 0.077), higher kurtosis of Dslow (P = 0.019) and frac (P = 0.025), and lower entropy of Dslow (P = 0.005) and frac (P = 0.001) within the ETA. Additionally, HGG exhibited lower mean frac in both ETA (P = 0.007) and PTEA (P = 0.017). Combining skewness of frac in ETA with clear tumor margin enhanced diagnostic performance, achieving an optimal AUC of 0.79. These findings suggest that histogram analysis of diffusion and perfusion characteristics in ETA and structural features can effectively differentiate HGG from SBM.
Keywords: Diffusion; Diffusion-weighted imaging; High-grade glioma; Perfusion; Solitary brain metastasis.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: J. Guo is an employee of GE Healthcare. The other authors have no conflicts of interest to declare. Ethics approval: The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The protocol was reviewed and approved by the Ethics Committee of Shanxi Provincial People’s Hospital/Fifth Hospital of Shanxi Medical University (2022 Research Review No. 153). Consent to participate: The informed consent was waived by the Ethics Committee of Shanxi Provincial People’s Hospital /Fifth Hospital of Shanxi Medical University (2022 Research Review No. 153). Consent to publish: Not applicable.
Figures
References
-
- Miller, K. D. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J. Clin.71, 381–406. 10.3322/caac.21693 (2021). - PubMed
-
- Sacks, P. & Rahman, M. Epidemiology of brain metastases. Neurosurg. Clin. N. Am.31, 481–488. 10.1016/j.nec.2020.06.001 (2020). - PubMed
-
- Horbinski, C. et al. NCCN Guidelines® insights: Central nervous system cancers, Version 2.2022. J. Natl. Compr. Canc. Netw.21, 12–20. 10.6004/jnccn.2023.0002 (2023). - PubMed
-
- Cha, S. et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am. J. Neuroradiol.28, 1078–1084. 10.3174/ajnr.A0484 (2007). - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
